Skip to main content
. 2024 Aug 22;18:1400702. doi: 10.3389/fninf.2024.1400702

Table 2.

Clinical and imaging information on training and testing sets.

Training set (n = 97) Testing set (n = 44)
Good N = 58 Poor N = 39 p Good N = 26 Poor N = 18 p
Age 67.97 ± 11.99 70.62 ± 11.91 0.287 74.92 ± 11.69 74.56 ± 8.87 0.911
Gender 29 (50.0%) 25 (64.1%) 0.170 13 (50.0%) 11 (61.1%) 0.467
Smoking 11 (19.0%) 8 (20.5%) 0.851 2 (7.7%) 4 (22.2%) 0.208
Hypertension 40 (69.0%) 34 (87.2%) 0.039 17 (65.4%) 15 (83.3%) 0.303
Diabetes 4 (6.9%) 10 (25.6%) 0.017 6 (23.1%) 1 (5.6%) 0.211
Atrial fibrillation 25 (43.1%) 17 (43.6%) 0.962 14 (53.8%) 13 (72.2%) 0.346
Use of anticoagulants 7 (12.1%) 5 (12.8%) 0.912 10 (38.5%) 3 (16.7%) 0.182
Hyperlipidemia 2 (3.4%) 2 (5.1%) 1.000 2 (7.7%) 1 (5.6%) 1.000
The NIHSS at admission 18.88 ± 6.01 24.38 ± 6.70 < 0.01 18.46 ± 6.88 24.61 ± 7.20 0.007
The ASPECT at admission (< 6 score) 18 (31.0%) 27 (69.2%) < 0.01 8 (30.8%) 11 (61.1%) 0.046
Bridging treatment 25 (43.1%) 12 (30.8%) 0.220 14 (53.8%) 9 (50.0%) 0.802
Time of operation 339.81 ± 155.52 368.51 ± 165.35 0.387 303.04 ± 115.17 309.22 ± 63.97 0.838
Good revascularization 55 (94.8%) 32 (82.1%) 0.084 21 (80.8%) 12 (66.7%) 0.288
mRS score at 3 m 2.38 ± 0.81 5.00 ± 0.86 < 0.01 2.35 ± 0.63 5.22 ± 0.81 < 0.01

HDL, high-density lipoprotein; LDL, low-density lipoprotein; APTT, activated partial thromboplastin time; PT, prothrombin time.